DGAP-News: Pi-Cardia Receives FDA IDE Approval for Pivotal Study with ShortCut(TM) Device
DGAP-News: Pi-Cardia Ltd. / Key word(s): Miscellaneous Pi-Cardia Receives FDA IDE Approval for Pivotal Study with ShortCut(TM) Device 26.07.2022 / 15:00 The issuer is solely responsible for the content of this announcement. Pi-Cardia Receives FDA IDE Approval for Pivotal Study with ShortCut(TM) ...
Source: boersennews.de